相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer
Yaqi Gao et al.
NEOPLASIA (2023)
Mining therapeutic targets from the antibiotic-resistant Campylobacter coli and virtual screening of natural product inhibitors against its riboflavin synthase
Khurshid Jalal et al.
MOLECULAR DIVERSITY (2023)
Differential analysis of Orientia tsutsugamushi genomes for therapeutic target identification and possible intervention through natural product inhibitor screening
Zarrin Basharat et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2022)
Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models
Jessica Queen et al.
MBIO (2022)
Riboflavin intake, MTRR genetic polymorphism (rs1532268) and gastric cancer risk in a Korean population: a case-control study
Y-Thanh Lu et al.
BRITISH JOURNAL OF NUTRITION (2022)
An in silico hierarchal approach for drug candidate mining and validation of natural product inhibitors against pyrimidine biosynthesis enzyme in the antibiotic-resistant Shigella flexneri
Zarrin Basharat et al.
INFECTION GENETICS AND EVOLUTION (2022)
In silico study to identify new monoamine oxidase type a (MAO-A) selective inhibitors from natural source by virtual screening and molecular dynamics simulation
Khurshid Jalal et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
Unraveling the crystal structure of Leptospira kmetyi riboflavin synthase and computational analyses for potential development of new antibacterials
Sayangku Nor Ariati Mohamad Aris et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota
Kaitlyn D. LaCourse et al.
CELL REPORTS (2022)
Enterotypical Prevotella and three novel bacterial biomarkers in preoperative stool predict the clinical outcome of colorectal cancer
Ji-Won Huh et al.
MICROBIOME (2022)
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients
Federica Bellerba et al.
NEOPLASIA (2022)
Nitroreductase-instructed supramolecular assemblies for microbiome regulation to enhance colorectal cancer treatments
Jiali Chen et al.
SCIENCE ADVANCES (2022)
Profiling Fusobacterium infection at high taxonomic resolution reveals lineage-specific correlations in colorectal cancer
Dexi Bi et al.
NATURE COMMUNICATIONS (2022)
Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling
Barath Udayasuryan et al.
SCIENCE SIGNALING (2022)
The Role of Fusobacterium nucleatum in Colorectal Cancer Cell Proliferation and Migration
Zihong Wu et al.
CANCERS (2022)
Tumour microbiomes and Fusobacterium genomics in Vietnamese colorectal cancer patients
Hoang N. H. Tran et al.
NPJ BIOFILMS AND MICROBIOMES (2022)
Proinflammatory and Cancer-Promoting Pathobiont Fusobacterium nucleatum Directly Targets Colorectal Cancer Stem Cells
Virve Cavallucci et al.
BIOMOLECULES (2022)
Whole-Transcriptome Sequencing Reveals Characteristics of Cancer Microbiome in Korean Patients with GI Tract Cancer: Fusobacterium nucleatum as a Therapeutic Target
Hyeok Ahn et al.
MICROORGANISMS (2022)
Rectal Cancer Presenting with Absceding Infection Due to Fusobacterium nucleatum
Sebastian Zundler et al.
PATHOGENS (2022)
Circulating IgA Antibodies Against Fusobacterium nucleatum Amyloid Adhesin FadA are a Potential Biomarker for Colorectal Neoplasia
Jung Eun Baik et al.
CANCER RESEARCH COMMUNICATIONS (2022)
Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas
Chia-Hui Lo et al.
JOURNAL OF BIOMEDICAL SCIENCE (2022)
Comparative Metabolic Pathways Analysis and Subtractive Genomics Profiling to Prioritize Potential Drug Targets Against Streptococcus pneumoniae
Kanwal Khan et al.
FRONTIERS IN MICROBIOLOGY (2022)
DEG 15, an update of the Database of Essential Genes that includes built-in analysis tools
Hao Luo et al.
NUCLEIC ACIDS RESEARCH (2021)
Pan-genomics, drug candidate mining and ADMET profiling of natural product inhibitors screened against Yersinia pseudotuberculosis
Zarrin Basharat et al.
GENOMICS (2021)
Therapeutic target identification via differential genome analysis of antibiotic resistant Shigella sonnei and inhibitor evaluation against a selected drug target
Zarrin Basharat et al.
INFECTION GENETICS AND EVOLUTION (2021)
Novel Targets and Mechanisms in Antimicrobial Drug Discovery
Donatella Tondi
ANTIBIOTICS-BASEL (2021)
A Comprehensive Computer Aided Vaccine Design Approach to Propose a Multi-Epitopes Subunit Vaccine against Genus Klebsiella Using Pan-Genomics, Reverse Vaccinology, and Biophysical Techniques
Khaled S. Allemailem
VACCINES (2021)
Malyngamide F Possesses Anti-Inflammatory and Antinociceptive Activity in Rat Models of Inflammation
Zhuocheng Li et al.
PAIN RESEARCH & MANAGEMENT (2021)
A newly developed PCR-based method revealed distinct Fusobacterium nucleatum subspecies infection patterns in colorectal cancer
Dexi Bi et al.
MICROBIAL BIOTECHNOLOGY (2021)
COG database update: focus on microbial diversity, model organisms, and widespread pathogens
Michael Y. Galperin et al.
NUCLEIC ACIDS RESEARCH (2021)
Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression
Lishay Parhi et al.
NATURE COMMUNICATIONS (2020)
Gradual polyploid genome evolution revealed by pan-genomic analysis of Brachypodium hybridum and its diploid progenitors
Sean P. Gordon et al.
NATURE COMMUNICATIONS (2020)
CEG 2.0: an updated database of clusters of essential genes including eukaryotic organisms
Shuo Liu et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2020)
The Incidence Rate of Colorectal Cancer in Saudi Arabia: An Observational Descriptive Epidemiological Analysis
Ahmad Almatroudi
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2020)
Genome and pan-genome analysis to classify emerging bacteria
Aurelia Caputo et al.
BIOLOGY DIRECT (2019)
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
Suhas Vasaikar et al.
CELL (2019)
A high-throughput screening for inhibitors of riboflavin synthase identifies novel antimicrobial compounds to treat brucellosis
Maria Ines Serer et al.
FEBS JOURNAL (2019)
A Review on the Special Radiotherapy Techniques of Colorectal Cancer
Shing Yau Tam et al.
FRONTIERS IN ONCOLOGY (2019)
Pathogenomics of Emerging Campylobacter Species
Daniela Costa et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Signaling pathways involved in colorectal cancer progression
Zahra Koveitypour et al.
CELL AND BIOSCIENCE (2019)
Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation
Vegard Torp Lien et al.
RSC ADVANCES (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Anti-Inflammatory, Anti-Diabetic, and Anti-Alzheimer's Effects of Prenylated Flavonoids from Okinawa Propolis: An Investigation by Experimental and Computational Studies
Md Shahinozzaman et al.
MOLECULES (2018)
Riboflavin and pantothenic acid biosynthesis are crucial for iron homeostasis and virulence in the pathogenic mold Aspergillus fumigatus
Anna-Maria Dietl et al.
VIRULENCE (2018)
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Susan Bullman et al.
SCIENCE (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
TaChung Yu et al.
CELL (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc
Jawad Abed et al.
CELL HOST & MICROBE (2016)
Versiquinazolines A-K, Fumiquinazoline-Type Alkaloids from the Gorgonian-Derived Fungus Aspergillus versicolor LZD-14-1
Zhongbin Cheng et al.
JOURNAL OF NATURAL PRODUCTS (2016)
Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
Chamutal Gur et al.
IMMUNITY (2015)
A new algorithm for essential proteins identification based on the integration of protein complex co-expression information and edge clustering coefficient
Jiawei Luo et al.
INTERNATIONAL JOURNAL OF DATA MINING AND BIOINFORMATICS (2015)
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
Douglas E. V. Pires et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Proteome mining for drug target identification in Listeria monocytogenes strain EGD-e and structure-based virtual screening of a candidate drug target penicillin binding protein 4
Aditya Narayan Sarangi et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2015)
High occurrence of Fusobacterium nucleatum and Clostridium difficile in the intestinal microbiota of colorectal carcinoma patients
Marcia H. Fukugaiti et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2015)
Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome
L. Flanagan et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Gastrointestinal Malignancy and the Microbiome
Maria T. Abreu et al.
GASTROENTEROLOGY (2014)
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
Sander Pronk et al.
BIOINFORMATICS (2013)
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Aleksandar D. Kostic et al.
CELL HOST & MICROBE (2013)
Identification and Characterization of Potential Therapeutic Candidates in Emerging Human Pathogen Mycobacterium abscessus: A Novel Hierarchical In Silico Approach
Buvaneswari Shanmugham et al.
PLOS ONE (2013)
Fusobacterium spp. and colorectal cancer: cause or consequence?
Temitope O. Keku et al.
TRENDS IN MICROBIOLOGY (2013)
MAP kinase genes and colon and rectal cancer
Martha L. Slattery et al.
CARCINOGENESIS (2012)
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Mauro Castellarin et al.
GENOME RESEARCH (2012)
VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors
Lihong Chen et al.
NUCLEIC ACIDS RESEARCH (2012)
History of protein-protein interactions: From egg-white to complex networks
Pascal Braun et al.
PROTEOMICS (2012)
Riboflavin Biosynthetic and Regulatory Factors as Potential Novel Anti-Infective Drug Targets
Quanxin Long et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
The SWISS-MODEL Repository and associated resources
Florian Kiefer et al.
NUCLEIC ACIDS RESEARCH (2009)
NCBIBLAST: a better web interface
Mark Johnson et al.
NUCLEIC ACIDS RESEARCH (2008)
Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae:: Implications for the microbial pan-genome
H Tettelin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
MUSCLE: multiple sequence alignment with high accuracy and high throughput
RC Edgar
NUCLEIC ACIDS RESEARCH (2004)